eli lilly stock retatrutide The thesis for biopharma stocks may be evolving away from obesity for the first time in four years, says Jared Holz of @MizuhoAmericas, He shares what he thinks investors will consider instead for the Eli Lilly Stock Outlook 2026:

Nugent AC, Martinez A, DAlfonso A, Zarate CA, Theodore WH

At 24 weeks, retatrutide (1 mg, 4 mg, 8 mg or 12 mg) met the primary endpoint for efficacy in participants with obesity or overweight without diabetes

Instead of containing semaglutide the active ingredient in Ozempic, Wegovy, and other grey-market GLP-1s, or another of its analogs this phony version includes ingredients like Supresa, a dubious saffron extract claimed to suppress appetite

The strategies that worked for you before might not be as effective anymore, and thats completely normal

Certainty of evidence was evaluated using the GRADE methodology

Inform your surgical and anaesthetic team of any supplements you are taking